Jim Healy

Ohmx Corp. develops bioelectronic detection devices. Its products include biosensor chip, portable point-of-care (POC) system, and prostate cancer aggressiveness biomaker. The company was founded by Thomas J. Meade on October 25, 2004 and is headquartered in Evanston, IL.

Tenex Health, Inc. develops and provides minimally invasive therapies for removal of diseased soft tissue and restoration of healthy musculoskeletal function. The firm specializes in procedures that allow physicians to identify, debride, and aspirate pain-generating pathologic soft tissue in tendons and other musculoskeletal structures of the elbow, knee, ankle, foot, and shoulder. The company was founded by Jagi Gill in 2009 and is headquartered in Lake Forest, CA.

Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD.

Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN.

California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA.

PLIVA, Inc. develops, produces, and sells drugs and pharmaceutical products. Its products include Ethosuximide, Fluoxetine, and Cyclosporine. The company was founded in 1921 and is headquartered in East Hanover, NJ.

Part of Roche Holding AG, Clinical Micro Sensors, Inc. is a company that manufactures instruments used in genetic diagnostics testing. The company is based in Pasadena, CA. The company was founded by Jon Faiz Kayyem. Clinical Micro Sensors was acquired by Osmetech Ltd. from Motorola, Inc. on August 10, 2005 for $2.45 million.

Barr Laboratories, Inc. develops and markets generic pharmaceuticals. The company was founded by Edwin A. Cohen in 1970 and is headquartered in Montvale, NJ.

Pictor Ltd. operates as a biotechnology company. It develops technology for multiplexed testing for blood and biological fluids. The firm?s products include PictArrayTM ToRCH ELISA, ENA ELISA, and HAE ELISA Kit. The company was founded by Krishnanand Kumble and Sarita Kumble in 2005 and is headquartered in Auckland, New Zealand.

VCI Partners LLC (VCI Partners) is a private equity and venture capital firm founded in 2011 by Ivan Mijatovic. The firm is headquartered in Charlotte, North Carolina.

Claremont BioSolutions LLC operates as a technology company which specializes in disposable devices. Its products include SimplePrep X8 automated lysis & nucleic acid extraction instrument, OmniLyse a rapid cell lysis kits, Homogenization kits, PureLyse, HisExpress, ALFRD, Legato a touchscreen syringe pumps, MicroMesh & transfer tips and filter tips. The company was founded in 2006 by Tracy Doebler, James D. Sterling, Robert Doebler and Ali Nadim and is headquartered in Upland, CA.

Inivata Ltd. develops new clinical applications for ctDNA analysis. It is a clinical cancer genomics company harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment. The firm is focused on developing clinical applications of ctDNA through collaborations with clinical oncologists at prominent academic institutions, leading community treatment centres and innovative biopharmaceutical companies. The company was founded by James Brenton, Tim Forshew, Rosenfeld Nitzan and Davina Gale on July 23, 2014 and is headquartered in Cambridge, the United Kingdom.